CHNC China Infrastructure Construct

CHNC Announces to Its Allies the Rebranding and Name Change to Cannabis Bioscience International Holdings

CHNC Announces to Its Allies the Rebranding and Name Change to Cannabis Bioscience International Holdings

HOUSTON, TX, April 24, 2023 (GLOBE NEWSWIRE) -- via -- CBIH, previously known as CHNC, and trading under the ticker symbol CHNC, today unveiled the rebranding of its identity, including a new logo as part of its strategy to better reflect CBIH’s focus, medical purpose, and vision for the future.

Starting today, the company has officially begun the process of changing all its digital content, including old logos, websites, videos, advertising, products, and marketing descriptions. This implicates communication with educational and pharmaceutical partners, allies, and e-commerce distributors around the world. By the end of July, the company will strive to have finished the process.

"With a clear goal of helping patients and being part of the development of medicine, we visualized our company as an infinite world where the points need to be connected; nature should connect with science, people should connect with medicine, and business could be connected to all of these points. The rebranding of our firm is rooted in our company’s heritage, as well our new logo better reflects our focus on the near future of medicine," says CBIH’s Research Director Doctor Jennifer Salguero, Ph.D. in Science, University of São Paulo, Brazil.

This rebrand marks a major milestone for our operations, to dispel doubts concerning the location and business of the company, which works with clinical trials, sleep studies, and cannabis education from its office in Houston, Texas. In addition, CBIH´s management wishes to reassure its students, clients, partners, and distributors that these changes will not represent any inconveniences. Thus, our company unequivocally reaffirms to continue to invest the time, human resources, and investment dollars needed to improve the quality of life of thousands of people by continuing to create non-traditional medicine in a traditional world.

To learn more visit:

For more information contact us at:

817/528-2475 for English

214/733-0868 for Spanish



EN
24/04/2023

Underlying

CHNCChina Infrastructure Construct

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on China Infrastructure Construct

 PRESS RELEASE
Free
CHNC China Infrastru...

CBIH Evaluates a Potential Reg A Offering of Approximately $1,000,000 ...

Houston, Texas--(Newsfile Corp. - January 21, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced today that it is in the evaluation stage of a potential financing transaction under Regulation A (Reg A), in an estimated amount in the order of $1,000,000, subject to change, internal review, and applicable market and compliance conditions.CBIH clarifies that this communication reflects a serious corporate and executive planning approach intended to protect business value and accelerate operati...

January 21, 2026 1 EN
 PRESS RELEASE
Free
CHNC China Infrastru...

CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr....

Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced today the launch of its Evidence Sprint 2026, an intensive execution phase designed to turn cannabinoid science into usable medical evidence: protocols, operational collaboration, and projects ready for competitive funding.CBIH confirms receipt of a communication from the Centers for Medicare & Medicaid Services (CMS) acknowledging Company's meeting request with CMS Administrator Dr. Mehmet Oz a...

January 12, 2026 1 EN
 PRESS RELEASE
Free
CHNC China Infrastru...

CBIH Launches Federal and Pharmaceutical Outreach Initiative to Accele...

Houston, Texas--(Newsfile Corp. - January 5, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced the launch of a national outreach and partnership initiative designed to capitalize on the accelerating federal momentum toward moving cannabis from Schedule I to Schedule III through the ongoing rescheduling rulemaking process. On December 18, 2025, a Presidential Executive Order directed the U.S. Attorney General to take necessary steps to complete the rulemaking process related to resche...

January 5, 2026 1 EN
 PRESS RELEASE
Free
CHNC China Infrastru...

CBIH Announces New Patent Initiative Targeting Opioid Addiction Throug...

Houston, Texas--(Newsfile Corp. - December 29, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced that it is pursuing a new patent for an investigational therapy designed to address opioid addiction, a condition that continues to claim tens of thousands of lives each year in the United States.According to U.S. public health data, more than 700,000 people have died from opioid-involved overdoses since the early 2000s. Despite recent progress, the crisis remains severe: in 2024 alone, a...

December 29, 2025 1 EN
 PRESS RELEASE
Free
CHNC China Infrastru...

CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Op...

Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces a landmark corporate and industry moment following recent indications that President Donald Trump will support federal actions that advance the rescheduling of marijuana from Schedule I to Schedule III. The development is widely regarded as one of the most consequential policy shifts in nearly two decades of national debate.After eighteen years of navigating scientific challenges, market volatility, stigma, and regulatory uncertainty, CBIH stated that this turn...

December 22, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch